Human Recombinant Arginase I [HuArgI (Co)-PEG5000]-Induced Arginine Depletion Inhibits Colorectal Cancer Cell Migration and Invasion
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human Recombinant Arginase I [HuArgI (Co)-PEG5000]-Induced Arginine Depletion Inhibits Colorectal Cancer Cell Migration and Invasion
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 23, Pages 6018
Publisher
MDPI AG
Online
2019-11-29
DOI
10.3390/ijms20236018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RHOG Activates RAC1 through CDC42 Leading to Tube Formation in Vascular Endothelial Cells
- (2019) Oula El Atat et al. Cells
- Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent
- (2019) Ghenwa Nasreddine et al. INVESTIGATIONAL NEW DRUGS
- Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells
- (2018) Marwa Al Hassan et al. Analytical Cellular Pathology
- Molecular basis and current strategies of therapeutic arginine depletion for cancer
- (2016) Livingstone Fultang et al. INTERNATIONAL JOURNAL OF CANCER
- Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer
- (2015) John M. Carethers et al. GASTROENTEROLOGY
- Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells
- (2015) Oula Khoury et al. JOURNAL OF NEURO-ONCOLOGY
- Argininosuccinate synthetase 1 suppression and arginine restriction inhibit cell migration in gastric cancer cell lines
- (2015) Yan-Shen Shan et al. Scientific Reports
- Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes
- (2015) Oncotarget
- Arginine deprivation affects glioblastoma cell adhesion, invasiveness and actin cytoskeleton organization by impairment of β-actin arginylation
- (2014) Iuliia Pavlyk et al. AMINO ACIDS
- StarD13 is a tumor suppressor in breast cancer that regulates cell motility and invasion
- (2014) SAMER HANNA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Bioengineered Human Arginase I with Enhanced Activity and Stability Controls Hepatocellular and Pancreatic Carcinoma Xenografts
- (2014) Evan S. Glazer et al. Translational Oncology
- Recombinant Human Arginase Toxicity in Mice Is Reduced by Citrulline Supplementation
- (2014) Jeremy P. Mauldin et al. Translational Oncology
- Signaling networks of Rho GTPases in cell motility
- (2013) Samer Hanna et al. CELLULAR SIGNALLING
- Molecular Pathways and Cellular Metabolism in Colorectal Cancer
- (2013) Hanne R. Hagland et al. DIGESTIVE SURGERY
- The regulation of RhoA at focal adhesions by StarD13 is important for astrocytoma cell motility
- (2013) Bassem D. Khalil et al. EXPERIMENTAL CELL RESEARCH
- Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells
- (2013) Rita Tanios et al. LEUKEMIA RESEARCH
- Effect of StarD13 on colorectal cancer proliferation, motility and invasion
- (2013) ANITA NASRALLAH et al. ONCOLOGY REPORTS
- Invasive matrix degradation at focal adhesions occurs via protease recruitment by a FAK–p130Cas complex
- (2012) Yu Wang et al. JOURNAL OF CELL BIOLOGY
- Deprivation of arginine by recombinant human arginase in prostate cancer cells
- (2012) Eddy C Hsueh et al. Journal of Hematology & Oncology
- Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells
- (2011) Vaidehi Agrawal et al. ANTI-CANCER DRUGS
- Replacing Mn2+with Co2+in Human Arginase I Enhances Cytotoxicity towardl-Arginine Auxotrophic Cancer Cell Lines
- (2010) Everett M. Stone et al. ACS Chemical Biology
- Pegylated arginase I: a potential therapeutic approach in T-ALL
- (2010) C. P. Hernandez et al. BLOOD
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
- (2010) Barbara Delage et al. INTERNATIONAL JOURNAL OF CANCER
- Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest
- (2009) T.L. Lam et al. CANCER LETTERS
- RhoA/ROCK-mediated switching between Cdc42- and Rac1-dependent protrusion in MTLn3 carcinoma cells
- (2008) Mirvat El-Sibai et al. EXPERIMENTAL CELL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started